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Abstract
Background: Recurrent hepatocellular carcinoma accompanied by a right atrial tumor thrombus is rare. No
standard treatment modality has been established. Surgical treatment may be the only curative treatment; however,
surgery has been considered high risk. We herein describe a patient who underwent resection of a recurrent right
atrial tumor thrombus under normothermic cardiopulmonary bypass on a beating heart.
Case presentation: A 60-year-old man underwent a right hepatectomy for hepatocellular carcinoma with diaphragm
invasion. During the preoperative cardiac screening, he was diagnosed with an old myocardial infarction with triple-vessel
coronary disease. Percutaneous coronary intervention was performed for the left anterior descending artery
and left circumflex coronary artery. High-grade stenosis remained in his right coronary artery. Nine months later, computed
tomography showed recurrent hepatocellular carcinoma in the diaphragm and a tumor thrombus extending from the
suprahepatic inferior vena cava into the right atrium. Surgical resection of the recurrent tumor was performed through a
right subcostal incision with xiphoid extension and median sternotomy. The recurrent tumor was incised with the
diaphragm and pericardium. Intraoperative ultrasonography revealed that the tumor thrombus was free from right atrium
wall invasion and that the right atrium could be clamped just proximal to the tumor thrombus. The right atrium,
infrahepatic vena cava, left and middle hepatic veins, and hepatoduodenal ligament were encircled. Cardiopulmonary
bypass was performed to prevent ischemic heart disease caused by intraoperative hypotension. Total hepatic vascular
exclusion was then performed under normothermic cardiopulmonary bypass on heart beating. The inferior vena cava wall
was incised. The tumor thrombus with the diaphragmatic recurrent tumor was resected en bloc. The patient had a
favorable clinical course without any complications.
Conclusion: The recurrent hepatocellular carcinoma in the diaphragm and the right atrial tumor thrombus were safely
resected using normothermic cardiopulmonary bypass on heart beating.
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Background
Hepatocellular carcinoma (HCC) with a right atrial
tumor thrombus (RATT) is associated with a poor prog-
nosis because heart failure, pulmonary embolism, or
cancer progression results in an unavoidable fatal out-
come. Transcatheter arterial chemoembolization, radio-
therapy, or surgery is used to treat the tumor thrombus
(TT); however, no standard treatment modality has been
established [1]. Improvements in surgical procedures
such as cardiopulmonary bypass (CPB) or total hepatic
vascular exclusion (THVE) have allowed for the per-
formance of aggressive surgery [2]. Surgical resection
may be the only curative treatment that increases
survival [3, 4]. However, few reports have described
HCC resection with a recurrent RATT. We herein
present a case involving resection of a recurrent RATT
using normothermic CPB on a beating heart.
Case presentation
A 60-year-old man underwent right hepatectomy with
the omentum and diaphragm for treatment of HCC with
diaphragm invasion. He had chronic hepatitis C with a
sustained virologic response to interferon treatment at
37 years old. An old myocardial infarction with triple-
vessel disease was found, and percutaneous coronary
intervention was performed for the left anterior
descending artery and left circumflex artery before sur-
gery. High-grade stenosis in his right coronary artery
was followed up without intervention because of the
presence of a small area of myocardial perfusion. After
right hepatectomy, he had a favorable clinical course
without any complications. After discharge from the hos-
pital, he was followed up by α-fetoprotein (AFP) measure-
ment, des-γ-carboxy prothrombin (DCP) measurement,
and ultrasonography. However, a recurrent tumor was
found by follow-up computed tomography (CT) 9 months
after surgery.
The physical examination of the patient was unre-
markable. His laboratory data were within the normal
ranges. The serum levels of tumor markers were as fol-
lows: carcinoembryonic antigen, 1.9 ng/mL; AFP, 3.6 ng/
mL; lens culinaris agglutinin A-reactive α-fetoprotein,
33 %; and DCP, 20 mAU/mL. Abdominal CT showed a
recurrent tumor in the diaphragm and a TT extending
from the inferior vena cava (IVC) to the right atrium
(RA) (Fig. 1a, b). Positron emission tomography/CT
images depicted the physiologic uptake of fluorine-18
fluorodeoxyglucose in both the diaphragm and RA tumor
(Fig. 1c), but no remote metastasis was observed (Fig. 1d).
Echocardiography demonstrated that the RATT did not
cause tricuspid valve occlusion, and the cardiac function
was good. Coronary angiography showed that the left an-
terior descending artery and left circumflex artery were
patent and that the right coronary artery had a high-grade
stenosis; the findings regarding his right coronary ar-
tery were the same as those observed during the pri-
mary operation. A cardiovascular medicine physician
assessed that the intervention for the stenosis had lit-
tle effect on his life prognosis. Because these exami-
nations revealed that the tumor was not invading the
RA wall and that the patient had well-preserved heart
function, resection was performed.
Surgery was performed through a right subcostal in-
cision with xiphoid extension and median sternotomy.
There was no ascites or peritoneal dissemination. The
adhesions involving the left liver, transverse colon,
and diaphragm were dissected. The recurrent tumor
of the diaphragm was incised with the pericardium.
Intraoperative histological examination revealed no
tumor in the resected diaphragm stump. Intraopera-
tive ultrasonography showed that the TT was free
from RA wall invasion and that the RA could be
clamped just proximal to the RATT. The RA, infrahe-
patic vena cava, left and middle hepatic veins, and
hepatoduodenal ligament were encircled with vascular
tape (Fig. 2a). We decided to use normothermic CPB
to minimize the ischemic damage to the heart caused
by intraoperative hypotension. CPB was established
with cannulation of the ascending aorta, right femoral
vein, and superior vena cava for drainage. Preceding
THVE, CPB was started under heparin administration
(25,000 units). THVE was performed under normo-
thermic CPB on heart beating as described below
(Fig. 3). First, the hepatoduodenal ligament was
clamped to stop the inflow to the liver. Next, the RA,
infrahepatic vena cava, and left and middle hepatic
veins were clamped. The IVC wall was incised
(Fig. 2b), and the RATT with the diaphragmatic
tumor was removed en bloc. The IVC wall was su-
tured closed in a simple continuous pattern (Fig. 2c).
The THVE and CPB times were 12 and 39 min, re-
spectively. The diaphragm defect was repaired with a
Gore-Tex® Soft Tissue Patch (W.L. Gore & Associates
Technologies Co., Ltd., Tokyo, Japan). The surgical
time was 739 min, and the intraoperative blood loss
was 5881 mL.
The patient had a favorable clinical course without
any complications and was discharged on postopera-
tive day 24. The diaphragm tumor and TT were
pathologically diagnosed as poorly differentiated HCC.
The diaphragmatic HCC had invaded the pericardium.
Viable tumor cells were present in both the surgical
stump of the diaphragm and IVC. The patient began
taking sorafenib on day 53 postoperatively. Although
magnetic resonance imaging revealed a recurrent
lesion in the right thoracic cavity and vertebral body,
the patient survived for 10 months after surgery and
was still alive at the time of this writing.
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Discussion
The incidence of HCC with a RATT or IVC TT usually
ranges from 1 to 4 % [5–7]. Recurrent HCC accompan-
ied by a RATT is rarely encountered. A RATT may
result in sudden death because of pulmonary embolism
or heart failure. Therefore, this condition should be sur-
gically treated as soon as possible [8–10]. Without any
treatment, the survival duration reportedly ranges from
2.4 to 2.7 months [11, 12].
The strategy for treatment of HCC with a RATT
usually involves combinations of surgery, radiotherapy,
transarterial chemoembolization, and chemotherapy
[13]. However, the standard treatment modality for
recurrent tumors remains controversial. Surgery can
prevent sudden death caused by a RATT, and patients
can achieve long-term survival [3, 14]. Even in patients
undergoing a noncurative operation for a RATT, sur-
gical resection might be beneficial. After prevention
of the life-threatening condition, these patients may
have the opportunity to be treated with adjuvant
chemotherapy [4].
The problem associated with surgical treatment of a
TT is the high operative risk to the patient. Procedures
such as THVE, CPB, and hypothermic cardiocirculatory
arrest have been used to minimize surgical stress [3].
THVE can decrease operative bleeding while the TT
inside the IVC is removed [15]. CPB is used to preserve
the intraoperative circulation. Hypothermic cardiocircu-
latory arrest also has the advantage of reducing operative
bleeding and liver damage [16]. Although CPB has
potential risks of coagulation dysfunction, transient




Fig. 1 Preoperative imaging studies. a Abdominal enhanced computed tomography revealed the tumor in the diaphragm (arrows) and the tumor
thrombus (arrowhead). b The tumor thrombus extended from the retrohepatic inferior vena cava to the right atrium. c Positron emission tomography
revealed the physiologic uptake of 18-fluorodeoxyglucose in both the diaphragm and right atrial tumor, d suggesting no remote metastasis
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no differences in clinical outcomes have been reported
[19]. In the present case, the patient had an old myocar-
dial infarction and high-grade stenosis remained in the
right coronary artery. In the preoperative conference
with the cardiovascular surgeon, we discussed how to
extract the tumor and prevent the cardinal damage.
Preoperatively, it seemed that we would have difficultly
extracting the RATT without an atriotomy. Moreover,
because of the patient’s coronary disease, we were plan-
ning to perform coronary artery bypass grafting (CABG)
if we encountered the need to stop the heart from beat-
ing to extract the tumor. After the preoperative confer-
ence, we prepared for the CPB. In fact, the RATT was
free from RA wall invasion and the RA could be
clamped just proximal to the RATT. However, when the
venous return decreased by hemostasis of the IVC, the
patient’s blood pressure dropped. Then, we performed
normothermic CPB without stopping the heart to avoid
ischemic damage. THVE and CPB helped to reduce
bleeding and preserve the operative circulation, respect-
ively. Although the RATT might have been extracted
with veno-venous bypass, we used CPB to avoid intraop-
erative hypotension.
There are many surgical case reports for HCC with
RATT [20]; however, surgery for recurrent RATT is rare.
Our search of the English literature (PubMed) revealed
four cases of resection of a recurrent HCC with a RATT
[21–24]. Two of these four cases involved CPB and
hypothermic circulatory arrest; both used CPB to reduce
intraoperative bleeding caused by atriotomy. Ohwada et al.
a
b c
Fig. 2 Operative findings. a White arrow shows the recurrent tumor in the diaphragm. The right atrium, infrahepatic inferior vena cava (IVC), left
and middle hepatic veins, and hepatoduodenal ligament were encircled with vascular tape. Single asterisk right atrium, double asterisk IVC, white
arrowhead hepatoduodenal ligament, black arrow IVC and hepatic vein. b The IVC wall was incised (yellow arrowheads), and the right atrial tumor
thrombus with the diaphragmatic tumor was removed en bloc. c The IVC wall was sutured closed in a simple continuous pattern
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[23] used CPB because a RATT was extending close to the
tricuspid valve. Wu et al. [24] used CPB because it was
impossible to perform THVE due to dense adhesions.
Conversely, we used CPB in our case to maintain the cor-
onary blood flow. In all cases, the RATT was removed en
bloc by incision of the IVC wall without any complications.
Although many potential problems are associated with
re-resection of a recurrent HCC with a RATT, such as
adhesions and liver or heart dysfunction, the combined use
of appropriate procedures would minimize the operative
morbidity and mortality.
Recurrence of HCC with a RATT is very rare; how-
ever, aggressive surgical resection can be performed
safely with the appropriate modality. CPB is one such
modality that allows for safe resection.
Conclusions
In summary, we have reported a rare case of HCC recur-
rence in the diaphragm with a TT extending into the
RA. Although the patient had ischemic heart disease, the
tumor could be resected without any complications
using CPB with heart beating.
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